` Comparison: GBT vs MDLN - Alpha Spread

GBT
vs
M
MDLN

Over the past 12 months, GBT has underperformed MDLN, delivering a return of -69% compared to the MDLN's 32% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
GBT
MDLN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

GBT Intrinsic Value
43.21 EUR
Undervaluation 81%
Intrinsic Value
Price
M
MDLN Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Guerbet SA
PAR:GBT
8.2 EUR
M
Medline Inc
NASDAQ:MDLN
41.75 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
GBT, MDLN

GBT
MDLN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Guerbet SA
Revenue
M
Medline Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
GBT, MDLN

GBT
MDLN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Guerbet SA
PAR:GBT
M
Medline Inc
NASDAQ:MDLN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

GBT
78%
MDLN
26.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Guerbet SA
M
Medline Inc

Operating Margin

GBT
4.2%
MDLN
8.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Guerbet SA
M
Medline Inc

Net Margin

GBT
1%
MDLN
4.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Guerbet SA
M
Medline Inc

FCF Margin

GBT
5.5%
MDLN
4.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Guerbet SA
M
Medline Inc

ROE

GBT
2%
MDLN
10.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Guerbet SA
M
Medline Inc

ROA

GBT
0.8%
MDLN
3%
LTM 3Y Avg 5Y Avg 10Y Avg
Guerbet SA
M
Medline Inc

ROIC

GBT
2.7%
MDLN
6.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Guerbet SA
M
Medline Inc

ROCE

GBT
4.3%
MDLN
6.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Guerbet SA
M
Medline Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
GBT, MDLN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
GBT, MDLN

Loading
GBT
MDLN
Difference
www.alphaspread.com

Performance By Year
GBT, MDLN

Loading
GBT
MDLN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare GBT to other stocks
7741
Hoya Corp
More expensive
vs GBT
ALC
Alcon AG
More expensive
vs GBT
COLO B
Coloplast A/S
More expensive
vs GBT
ALGN
Align Technology Inc
More expensive
vs GBT
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett